Calculating clinical progression rates in Parkinson's disease: Methods matter

Parkinsonism and Related Disorders

Volumn 20, Issue 11, 2014, Pages 1263-1267

  Marinus, Johan ^a   van der Heeden, Jorine F ^a   van Hilten, Jacobus J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cohort studies; Methodology; Parkinson's disease; Progression

Indexed keywords

ADULT; ANALYTIC METHOD; ANALYTICAL PARAMETERS; ANNUAL PROGRESSION RATE; ARTICLE; CLINICAL PROGRESSION RATE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION COEFFICIENT; CROSS-SECTIONAL METHOD; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LINEAR REGRESSION MODEL; LONGITUDINAL METHOD; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; RANK ORDER CORRELATION; SCOPA ACTIVITY OF DAILY LIVING SCORE; SCOPA MOTOR SCORE; SCORING SYSTEM; STATISTICAL MODEL; AGED; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; DISABILITY; MIDDLE AGED; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VERY ELDERLY;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84908600233     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.08.009     Document Type: Article

References (16)

1. Jellinger K.A. Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts. Mov Disord 2012, 27:8-30.
2. Lewis S.J., Foltynie T., Blackwell A.D., Robbins T.W., Owen A.M., Barker R.A. Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. JNeurol Neurosurg Psychiatry 2005, 76:343-348.
3. Baumann C.R., Held U., Valko P.O., Wienecke M., Waldvogel D. Body side and predominant motor features at the onset of Parkinson's disease are linked to motor and nonmotor progression. Mov Disord 2014, 29:207-213.
4. Erro R., Vitale C., Amboni M., Picillo M., Moccia M., Longo K., et al. The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. PLoS One 2013, 8:e70244.
5. Post B., Speelman J.D., de Haan R.J. Clinical heterogeneity in newly diagnosed Parkinson's disease. JNeurol 2008, 255:716-722.
6. Reijnders J.S., Ehrt U., Lousberg R., Aarsland D., Leentjens A.F. The association between motor subtypes and psychopathology in Parkinson's disease. Parkinsonism Relat Disord 2009, 15:379-382.
7. Schrag A., Quinn N.P., Ben-Shlomo Y. Heterogeneity of Parkinson's disease. JNeurol Neurosurg Psychiatry 2006, 77:275-276.
8. Holford N. Disease progression and neuroscience. JPharmacokinet Pharmacodyn 2013, 40:369-376.
9. Kempster P.A., O'Sullivan S.S., Holton J.L., Revesz T., Lees A.J. Relationships between age and late progression of Parkinson's disease: a clinico-pathological study. Brain 2010, 133:1755-1762.
10. Verbaan D., Marinus J., Visser M., van Rooden S.M., Stiggelbout A.M., van Hilten J.J. Patient-reported autonomic symptoms in Parkinson disease. Neurology 2007, 69:333-341.
11. Gibb W.R., Lees A.J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. JNeurol Neurosurg Psychiatry 1988, 51:745-752.
12. Marinus J., Visser M., Stiggelbout A.M., Rabey J.M., Martinez-Martin P., Bonuccelli U., et al. Ashort scale for the assessment of motor impairments and disabilities in Parkinson's disease: the SPES/SCOPA. JNeurol Neurosurg Psychiatry 2004, 75:388-395.
13. Herman T., Inbar-Borovsky N., Brozgol M., Giladi N., Hausdorff J.M. The Dynamic Gait Index in healthy older adults: the role of stair climbing, fear of falling and gender. Gait Posture 2009, 29:237-241.
14. Esselink R.A., de Bie R.M., de Haan R.J., Lenders M.W., Nijssen P.C., Staal M.J., et al. Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: a randomized trial. Neurology 2004, 62:201-207.
15. Evans J.R., Mason S.L., Williams-Gray C.H., Foltynie T., Brayne C., Robbins T.W., et al. The natural history of treated Parkinson's disease in an incident, community based cohort. JNeurol Neurosurg Psychiatry 2011, 82:1112-1118.
16. Kuramoto L., Cragg J., Nandhagopal R., Mak E., Sossi V., Fuente-Fernandez R., et al. The nature of progression in Parkinson's disease: an application of non-linear, multivariate, longitudinal random effects modelling. PLoS One 2013, 8:e76595.